Biological Hazard Open Access Journals
A natural danger, or biohazard, which is called as natural substance that represents a danger to the soundness of living life forms, essentially people. This could include a sample of a microorganism, virus or toxin that can adversely affect human health. A biohazard could even be a substance harmful to other animals. The term and its associated symbol are generally used as a warning, in order that those potentially exposed to the substances will know to require precautions. At this level precautions against the biohazardous materials in question are minimal, presumably involving gloves and a few kind of facial protection. Bacteria and
viruses that cause only mild disease to humans, or are difficult to contract via aerosol during a lab setting, like
hepatitis A , B, and C, some
influenza A strains, Lyme disease, salmonella, mumps, measles, scrapie,
dengue fever, and HIV. Routine diagnostic work with clinical specimens are often done safely at grade 2, using grade 2 practices and procedures. Exploration work (counting co-development,
infection replication studies, or controls including concentrated infection) which are regularly cleared out a BSL-2 (P2) office, utilizing BSL-3 practices and methods.Bacteria and
viruses which will cause severe to fatal disease in humans, except for which vaccines or other treatments exist, like anthrax, West Nile virus, Venezuelan equine encephalomyelitis , SARS virus, MERS coronavirus, hantaviruses, tuberculosis, typhus, valley fever, Rocky Mountain rickettsial disease , yellow jack , and malaria.
High Impact List of Articles
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
Relevant Topics in Clinical